Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kayla G. Barnes is active.

Publication


Featured researches published by Kayla G. Barnes.


Proceedings of the National Academy of Sciences of the United States of America | 2013

Directionally selected cytochrome P450 alleles are driving the spread of pyrethroid resistance in the major malaria vector Anopheles funestus

Jacob M. Riveron; Helen Irving; Miranda Ndula; Kayla G. Barnes; Sulaiman S. Ibrahim; Mark J. I. Paine; Charles S. Wondji

Pyrethroid insecticides are critical for malaria control in Africa. However, resistance to this insecticide class in the malaria vector Anopheles funestus is spreading rapidly across Africa, threatening the success of ongoing and future malaria control programs. The underlying resistance mechanisms driving the spread of this resistance in wild populations remain largely unknown. Here, we show that increased expression of two tandemly duplicated P450 genes, CYP6P9a and CYP6P9b, is the main mechanism driving pyrethroid resistance in Malawi and Mozambique, two southern African countries where this insecticide class forms the mainstay of malaria control. Genome-wide transcription analysis using microarray and quantitative RT-PCR consistently revealed that CYP6P9a and CYP6P9b are the two genes most highly overexpressed (>50-fold; q < 0.01) in permethrin-resistant mosquitoes. Transgenic expression of CYP6P9a and CYP6P9b in Drosophila melanogaster demonstrated that elevated expression of either of these genes confers resistance to both type I (permethrin) and type II (deltamethrin) pyrethroids. Functional characterization of recombinant CYP6P9b confirmed that this protein metabolized both type I (permethrin and bifenthrin) and type II (deltamethrin and Lambda-cyhalothrin) pyrethroids but not DDT. Variability analysis identified that a single allele of each of these genes is predominantly associated with pyrethroid resistance in field populations from both countries, which is suggestive of a single origin of this resistance that has since spread across the region. Urgent resistance management strategies should be implemented in this region to limit a further spread of this resistance and minimize its impact on the success of ongoing malaria control programs.


Proceedings of the National Academy of Sciences of the United States of America | 2012

Impact of pyrethroid resistance on operational malaria control in Malawi

Charles S. Wondji; Michael Coleman; Immo Kleinschmidt; Themba Mzilahowa; Helen R. Irving; Miranda Ndula; Andrea M. Rehman; John C. Morgan; Kayla G. Barnes; Janet Hemingway

The impact of insecticide resistance on insect-borne disease programs is difficult to quantify. The possibility of eliminating malaria in high-transmission settings is heavily dependent on effective vector control reducing disease transmission rates. Pyrethroids are the dominant insecticides used for malaria control, with few options for their replacement. Their failure will adversely affect our ability to control malaria. Pyrethroid resistance has been selected in Malawi over the last 3 y in the two major malaria vectors Anopheles gambiae and Anopheles funestus, with a higher frequency of resistance in the latter. The resistance in An. funestus is metabolically based and involves the up-regulation of two duplicated P450s. The same genes confer resistance in Mozambican An. funestus, although the levels of up-regulation differ. The selection of resistance over 3 y has not increased malaria transmission, as judged by annual point prevalence surveys in 1- to 4-y-old children. This is true in areas with long-lasting insecticide-treated nets (LLINs) alone or LLINs plus pyrethroid-based insecticide residual spraying (IRS). However, in districts where IRS was scaled up, it did not produce the expected decrease in malaria prevalence. As resistance increases in frequency from this low initial level, there is the potential for vector population numbers to increase with a concomitant negative impact on control efficacy. This should be monitored carefully as part of the operational activities in country.


PLOS Genetics | 2011

Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum.

Daria Van Tyne; Daniel J. Park; Stephen F. Schaffner; Daniel E. Neafsey; Elaine Angelino; Joseph F. Cortese; Kayla G. Barnes; David M. Rosen; Amanda K Lukens; Rachel Daniels; Danny A. Milner; Charles Johnson; Ilya Shlyakhter; Sharon R. Grossman; Justin S. Becker; Daniel Yamins; Elinor K. Karlsson; Daouda Ndiaye; Ousmane Sarr; Souleymane Mboup; Christian T. Happi; Nicholas A. Furlotte; Eleazar Eskin; Hyun Min Kang; Daniel L. Hartl; Bruce W. Birren; Roger Wiegand; Eric S. Lander; Dyann F. Wirth; Sarah K. Volkman

The Plasmodium falciparum parasites ability to adapt to environmental pressures, such as the human immune system and antimalarial drugs, makes malaria an enduring burden to public health. Understanding the genetic basis of these adaptations is critical to intervening successfully against malaria. To that end, we created a high-density genotyping array that assays over 17,000 single nucleotide polymorphisms (∼1 SNP/kb), and applied it to 57 culture-adapted parasites from three continents. We characterized genome-wide genetic diversity within and between populations and identified numerous loci with signals of natural selection, suggesting their role in recent adaptation. In addition, we performed a genome-wide association study (GWAS), searching for loci correlated with resistance to thirteen antimalarials; we detected both known and novel resistance loci, including a new halofantrine resistance locus, PF10_0355. Through functional testing we demonstrated that PF10_0355 overexpression decreases sensitivity to halofantrine, mefloquine, and lumefantrine, but not to structurally unrelated antimalarials, and that increased gene copy number mediates resistance. Our GWAS and follow-on functional validation demonstrate the potential of genome-wide studies to elucidate functionally important loci in the malaria parasite genome.


Nature | 2017

Zika virus evolution and spread in the Americas

Hayden C. Metsky; Christian B. Matranga; Shirlee Wohl; Stephen F. Schaffner; Catherine A. Freije; Sarah M. Winnicki; Kendra West; James Qu; Mary Lynn Baniecki; Adrianne Gladden-Young; Aaron E. Lin; Christopher Tomkins-Tinch; Simon H. Ye; Daniel J. Park; Cynthia Y. Luo; Kayla G. Barnes; Rickey R. Shah; Bridget Chak; Giselle Barbosa-Lima; Edson Delatorre; Yasmine Rangel Vieira; Lauren M. Paul; Amanda L. Tan; Carolyn M. Barcellona; Mario C. Porcelli; Chalmers Vasquez; Andrew Cannons; Marshall R. Cone; Kelly N. Hogan; Edgar W. Kopp

Although the recent Zika virus (ZIKV) epidemic in the Americas and its link to birth defects have attracted a great deal of attention, much remains unknown about ZIKV disease epidemiology and ZIKV evolution, in part owing to a lack of genomic data. Here we address this gap in knowledge by using multiple sequencing approaches to generate 110 ZIKV genomes from clinical and mosquito samples from 10 countries and territories, greatly expanding the observed viral genetic diversity from this outbreak. We analysed the timing and patterns of introductions into distinct geographic regions; our phylogenetic evidence suggests rapid expansion of the outbreak in Brazil and multiple introductions of outbreak strains into Puerto Rico, Honduras, Colombia, other Caribbean islands, and the continental United States. We find that ZIKV circulated undetected in multiple regions for many months before the first locally transmitted cases were confirmed, highlighting the importance of surveillance of viral infections. We identify mutations with possible functional implications for ZIKV biology and pathogenesis, as well as those that might be relevant to the effectiveness of diagnostic tests.


Genome Biology | 2011

Hybrid selection for sequencing pathogen genomes from clinical samples

Alexandre Melnikov; Kevin Galinsky; Peter Rogov; Timothy Fennell; Daria Van Tyne; Carsten Russ; Rachel Daniels; Kayla G. Barnes; James Bochicchio; Daouda Ndiaye; Papa Diogoye Séne; Dyann F. Wirth; Chad Nusbaum; Sarah K. Volkman; Bruce W. Birren; Andreas Gnirke; Daniel E. Neafsey

We have adapted a solution hybrid selection protocol to enrich pathogen DNA in clinical samples dominated by human genetic material. Using mock mixtures of human and Plasmodium falciparum malaria parasite DNA as well as clinical samples from infected patients, we demonstrate an average of approximately 40-fold enrichment of parasite DNA after hybrid selection. This approach will enable efficient genome sequencing of pathogens from clinical samples, as well as sequencing of endosymbiotic organisms such as Wolbachia that live inside diverse metazoan phyla.


Nature | 2017

Genomic epidemiology reveals multiple introductions of Zika virus into the United States

Nathan D. Grubaugh; Jason T. Ladner; Moritz U. G. Kraemer; Gytis Dudas; Amanda L. Tan; Karthik Gangavarapu; Michael R. Wiley; Stephen White; Julien Thézé; Diogo M. Magnani; Karla Prieto; Daniel Reyes; Andrea M. Bingham; Lauren M. Paul; Refugio Robles-Sikisaka; Glenn Oliveira; Darryl Pronty; Carolyn M. Barcellona; Hayden C. Metsky; Mary Lynn Baniecki; Kayla G. Barnes; Bridget Chak; Catherine A. Freije; Adrianne Gladden-Young; Andreas Gnirke; Cynthia Y. Luo; Bronwyn MacInnis; Christian B. Matranga; Daniel J. Park; James Qu

Zika virus (ZIKV) is causing an unprecedented epidemic linked to severe congenital abnormalities. In July 2016, mosquito-borne ZIKV transmission was reported in the continental United States; since then, hundreds of locally acquired infections have been reported in Florida. To gain insights into the timing, source, and likely route(s) of ZIKV introduction, we tracked the virus from its first detection in Florida by sequencing ZIKV genomes from infected patients and Aedes aegypti mosquitoes. We show that at least 4 introductions, but potentially as many as 40, contributed to the outbreak in Florida and that local transmission is likely to have started in the spring of 2016—several months before its initial detection. By analysing surveillance and genetic data, we show that ZIKV moved among transmission zones in Miami. Our analyses show that most introductions were linked to the Caribbean, a finding corroborated by the high incidence rates and traffic volumes from the region into the Miami area. Our study provides an understanding of how ZIKV initiates transmission in new regions.


PLOS ONE | 2014

Widespread Pyrethroid and DDT Resistance in the Major Malaria Vector Anopheles funestus in East Africa Is Driven by Metabolic Resistance Mechanisms

Charles Mulamba; Jacob M. Riveron; Sulaiman S. Ibrahim; Helen Irving; Kayla G. Barnes; Louis G. Mukwaya; Josephine Birungi; Charles S. Wondji

Background Establishing the extent, geographical distribution and mechanisms of insecticide resistance in malaria vectors is a prerequisite for resistance management. Here, we report a widespread distribution of insecticide resistance in the major malaria vector An. funestus across Uganda and western Kenya under the control of metabolic resistance mechanisms. Methodology/Principal Findings Female An. funestus collected throughout Uganda and western Kenya exhibited a Plasmodium infection rate between 4.2 to 10.4%. Widespread resistance against both type I (permethrin) and II (deltamethrin) pyrethroids and DDT was observed across Uganda and western Kenya. All populations remain highly susceptible to carbamate, organophosphate and dieldrin insecticides. Knockdown resistance plays no role in the pyrethroid and DDT resistance as no kdr mutation associated with resistance was detected despite the presence of a F1021C replacement. Additionally, no signature of selection was observed on the sodium channel gene. Synergist assays and qRT-PCR indicated that metabolic resistance plays a major role notably through elevated expression of cytochrome P450s. DDT resistance mechanisms differ from West Africa as the L119F-GSTe2 mutation only explains a small proportion of the genetic variance to DDT resistance. Conclusion The extensive distribution of pyrethroid and DDT resistance in East African An. funestus populations represents a challenge to the control of this vector. However, the observed carbamate and organophosphate susceptibility offers alternative solutions for resistance management.


BMC Genomics | 2014

The highly polymorphic CYP6M7 cytochrome P450 gene partners with the directionally selected CYP6P9a and CYP6P9b genes to expand the pyrethroid resistance front in the malaria vector Anopheles funestus in Africa

Jacob M. Riveron; Sulaiman S. Ibrahim; Emmanuel Chanda; Themba Mzilahowa; Nelson Cuamba; Helen Irving; Kayla G. Barnes; Miranda Ndula; Charles S. Wondji

BackgroundPyrethroid resistance in the major malaria vector Anopheles funestus is rapidly expanding across Southern Africa. It remains unknown whether this resistance has a unique origin with the same molecular basis or is multifactorial. Knowledge of the origin, mechanisms and evolution of resistance are crucial to designing successful resistance management strategies.ResultsHere, we established the resistance profile of a Zambian An. funestus population at the northern range of the resistance front. Similar to other Southern African populations, Zambian An. funestus mosquitoes are resistant to pyrethroids and carbamate, but in contrast to populations in Mozambique and Malawi, these insects are also DDT resistant. Genome-wide microarray-based transcriptional profiling and qRT-PCR revealed that the cytochrome P450 gene CYP6M7 is responsible for extending pyrethroid resistance northwards. Indeed, CYP6M7 is more over-expressed in Zambia [fold-change (FC) 37.7; 13.2 for qRT-PCR] than CYP6P9a (FC15.6; 8.9 for qRT-PCR) and CYP6P9b (FC11.9; 6.5 for qRT-PCR), whereas CYP6P9a and CYP6P9b are more highly over-expressed in Malawi and Mozambique. Transgenic expression of CYP6M7 in Drosophila melanogaster coupled with in vitro assays using recombinant enzymes and assessments of kinetic properties demonstrated that CYP6M7 is as efficient as CYP6P9a and CYP6P9b in conferring pyrethroid resistance. Polymorphism patterns demonstrate that these genes are under contrasting selection forces: the exceptionally diverse CYP6M7 likely evolves neutrally, whereas CYP6P9a and CYP6P9b are directionally selected. The higher variability of CYP6P9a and CYP6P9b observed in Zambia supports their lesser role in resistance in this country.ConclusionPyrethroid resistance in Southern Africa probably has multiple origins under different evolutionary forces, which may necessitate the design of different resistance management strategies.


Molecular Biology and Evolution | 2012

SNP Genotyping Identifies New Signatures of Selection in a Deep Sample of West African Plasmodium falciparum Malaria Parasites

Alfred Amambua-Ngwa; Daniel J. Park; Sarah K. Volkman; Kayla G. Barnes; Amy K. Bei; Amanda K Lukens; Papa Diogoye Séne; Daria Van Tyne; Daouda Ndiaye; Dyann F. Wirth; David J. Conway; Daniel E. Neafsey; Stephen F. Schaffner

We used a high-density single-nucleotide polymorphism array to genotype 75 Plasmodium falciparum isolates recently collected from Senegal and The Gambia to search for signals of selection in this malaria endemic region. We found little geographic or temporal stratification of the genetic diversity among the sampled parasites. Through application of the iHS and REHH haplotype-based tests for positive selection, we found evidence of recent selective sweeps at a known drug resistance locus, at several known antigenic loci, and at several genomic regions not previously identified as sites of recent selection. We discuss the value of deep population-specific genomic analyses for identifying selection signals within sampled endemic populations of parasites, which may correspond to local selection pressures such as distinctive therapeutic regimes or mosquito vectors.


Malaria Journal | 2012

Human cerebral malaria and Plasmodium falciparum genotypes in Malawi

Danny A. Milner; Jimmy Vareta; Clarissa Valim; Jacqui Montgomery; Rachel Daniels; Sarah K. Volkman; Daniel E. Neafsey; Daniel J. Park; Stephen F. Schaffner; Nira Mahesh; Kayla G. Barnes; David M. Rosen; Amanda K Lukens; Daria Van-Tyne; Roger Wiegand; Pardis C. Sabeti; Karl B. Seydel; Simon J. Glover; Steve Kamiza; Malcolm E. Molyneux; Terrie E. Taylor; Dyann F. Wirth

BackgroundCerebral malaria, a severe form of Plasmodium falciparum infection, is an important cause of mortality in sub-Saharan African children. A Taqman 24 Single Nucleotide Polymorphisms (SNP) molecular barcode assay was developed for use in laboratory parasites which estimates genotype number and identifies the predominant genotype.MethodsThe 24 SNP assay was used to determine predominant genotypes in blood and tissues from autopsy and clinical patients with cerebral malaria.ResultsSingle genotypes were shared between the peripheral blood, the brain, and other tissues of cerebral malaria patients, while malaria-infected patients who died of non-malarial causes had mixed genetic signatures in tissues examined. Children with retinopathy-positive cerebral malaria had significantly less complex infections than those without retinopathy (OR = 3.7, 95% CI [1.51-9.10]).The complexity of infections significantly decreased over the malaria season in retinopathy-positive patients compared to retinopathy-negative patients.ConclusionsCerebral malaria patients harbour a single or small set of predominant parasites; patients with incidental parasitaemia sustain infections involving diverse genotypes. Limited diversity in the peripheral blood of cerebral malaria patients and correlation with tissues supports peripheral blood samples as appropriate for genome-wide association studies of parasite determinants of pathogenicity.

Collaboration


Dive into the Kayla G. Barnes's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles S. Wondji

Liverpool School of Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Helen Irving

Liverpool School of Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amanda L. Tan

Florida Gulf Coast University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lauren M. Paul

Florida Gulf Coast University

View shared research outputs
Researchain Logo
Decentralizing Knowledge